Next Article in Journal
Trastuzumab-Induced Cardiotoxicity: Testing a Clinical Risk Score in a Real-World Cardio-Oncology Population
Previous Article in Journal
Linkage of Clinical Trial and Administrative Data: A Survey of Cancer Patient Preferences
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 24
Issue 3
10.3747/co.24.3432
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Resource Utilization and Costs of Managing Patients with Advanced Melanoma: A Canadian Population-Based Study

by
F. Gwadry-Sridhar
1,
Soodeh Nikan
2,*,
A. Hamou
2,
S. J. Seung
3,
T. Petrella
4,
A. M. Joshua
5,
S. Ernst
6 and
N. Mittmann
4
1
University of Western Ontario, London, ON N6A 3K7, Canada
2
Pulse Infoframe, University of Western Ontario, 1151 Richmond Street, London, ON N6A 3K7, Canada
3
Health Outcomes and Pharmaco Economics (HOPE) Research Centre, Sunnybrook Research Institute, Toronto, ON, Canada
4
Sunnybrook Health Sciences Centre, Toronto, ON, Canada
5
Princess Margaret Hospital, Toronto, ON, Canada
6
London Regional Cancer Program, London, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2017, 24(3), 168-175; https://doi.org/10.3747/co.24.3432
Submission received: 4 March 2017 / Revised: 4 April 2017 / Accepted: 6 May 2017 / Published: 1 June 2017

Abstract

Background: The use and detailed costs of services provided for people with advanced melanoma (aMEL) are not well known. We conducted an analysis to determine the use of health care services and the associated costs delineated by relevant attributable costs, which we defined for subjects in the province of Ontario. Methods: Through the Ontario Cancer Data Linkage Project, a cohort of amel patients with diagnoses between 31 August 2005 and 2012 (follow-up to 2013) and with valid International Classification of Diseases (9th revision, Clinical Modification) 172 codes and histology codes was identified. A cohort of individuals with amel having a combination of at least 1 palliative, 1 medical oncology, and 1 hospitalization code was generated. The health system services used by this population were clustered into hospitalization, palliation, physician medical visits, medication, homecare, laboratory, diagnostics, and other resources. Overall rates of use and disaggregated costs were determined by phase of care for the entire cohort. Results: The mean age for the 2748 individuals in the cohort was 67 years. The greater proportion of the patients were men (65.6%) and were more than 65 years of age (>50%). In this advanced cohort, fewer than 45% of patients were alive 3 years after the malignant melanoma diagnosis. The average annual cost per patient over the time horizon was $6551. At $15,830, year 1 after diagnosis was the most expensive, followed by year 2, at $8166. Conclusions: Our data provide a baseline for the costs associated with aMEL treatment. Future studies will include newer agents and comparative effectiveness research for personalized therapies.
Keywords: advanced melanoma; resource utilization cost; outcomes of treatment; Ontario cd-link advanced melanoma; resource utilization cost; outcomes of treatment; Ontario cd-link

Share and Cite

MDPI and ACS Style

Gwadry-Sridhar, F.; Nikan, S.; Hamou, A.; Seung, S.J.; Petrella, T.; Joshua, A.M.; Ernst, S.; Mittmann, N. Resource Utilization and Costs of Managing Patients with Advanced Melanoma: A Canadian Population-Based Study. Curr. Oncol. 2017, 24, 168-175. https://doi.org/10.3747/co.24.3432

AMA Style

Gwadry-Sridhar F, Nikan S, Hamou A, Seung SJ, Petrella T, Joshua AM, Ernst S, Mittmann N. Resource Utilization and Costs of Managing Patients with Advanced Melanoma: A Canadian Population-Based Study. Current Oncology. 2017; 24(3):168-175. https://doi.org/10.3747/co.24.3432

Chicago/Turabian Style

Gwadry-Sridhar, F., Soodeh Nikan, A. Hamou, S. J. Seung, T. Petrella, A. M. Joshua, S. Ernst, and N. Mittmann. 2017. "Resource Utilization and Costs of Managing Patients with Advanced Melanoma: A Canadian Population-Based Study" Current Oncology 24, no. 3: 168-175. https://doi.org/10.3747/co.24.3432

APA Style

Gwadry-Sridhar, F., Nikan, S., Hamou, A., Seung, S. J., Petrella, T., Joshua, A. M., Ernst, S., & Mittmann, N. (2017). Resource Utilization and Costs of Managing Patients with Advanced Melanoma: A Canadian Population-Based Study. Current Oncology, 24(3), 168-175. https://doi.org/10.3747/co.24.3432

Article Metrics

Back to TopTop